Potentially inappropriate medication in palliative care patients according to STOPP-Frail criteria.

Daniel Sevilla-SanchezNúria Molist-BrunetJoan Espaulella-PanicotJavier González-BuenoNúria Solà-BonadaJordi Amblàs-NovellasCarles Codina-Jané

Published in: European geriatric medicine (2018)

PIMs according to STOPP-Frail are often used in palliative care patients. PIMs were associated with polypharmacy, but no related morbidity or mortality effects have been observed.

Keyphrases

palliative care
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
healthcare
advanced cancer
cardiovascular disease
risk factors
coronary artery disease
adverse drug